15 Sep 2014
52° Clear
Patch Instagram photo by daniellemastersonbooks
Patch Instagram photo by longunderwearman
Patch Instagram photo by quadrofoglio
Patch Instagram photo by athomeinmygarden
Patch Instagram photo by daniellemastersonbooks
Patch Instagram photo by healthandbeautynz
Patch Instagram photo by andreagazeapt
Patch Instagram photo by reh_22
Patch Instagram photo by athomeinmygarden

Read: Senators' Letter to Fridley-based Medtronic

Lawmakers ask med-tech company for answers on Infuse device.

Three U.S. senators sent a letter to Fridley-based this week, asking the company how it tracks its products' performance.

The letter, one of the five sent to med-tech firms, specifically mentions Medtronic's product Infuse, citing "allegations that researchers who received funds from Medtronic, sometimes millions of dollars, did not report negative findings from clinical trials."

The Dec. 13, 2011, letter is addressed to Medtronic Chairman and CEO Omar Ishrak, who .

Senators Charles Grassley (R-IA), Herb Kohl (D-WI) and Richard Blumenthal (D-CT) signed the letter. The same three are sponsors of new legislation to require manufacturers to monitor their devices in patients.

Medtronic told the Star Tribune"We have received the letter and are working to comply with their request."

Share This Article